Human skin mast cells: In vitro and in vivo studies

Annals of Allergy, Asthma and Immunology

Volumn 83, Issue 5, 1999, Pages 471-475

  Church, Martin K ^a   Clough, Geraldine F ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; BRADYKININ; CODEINE; COMPLEMENT COMPONENT C5A RECEPTOR; COMPOUND 48-80; GUANINE NUCLEOTIDE BINDING PROTEIN; HISTAMINE; IMMUNOGLOBULIN E; LEUKOTRIENE C4; PROSTAGLANDIN D2; PROTEIN TYROSINE KINASE; SOMATOSTATIN; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

CELL DENSITY; CELL MATURATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MAST CELL; PRIORITY JOURNAL; REVIEW; SKIN;

EID: 0032734177     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62853-0     Document Type: Article

References (39)

1. Castells MC, Friend DS, Bunnell CA, et al. The presence of membrane-bound stem cell factor on highly immature nonmetachromatic mast cells in the peripheral blood of a patient with aggressive systemic mastocytosis. J Allergy Clin Immunol 1996;98: 831-840.
2. Furitsu T, Saito H, Dvorak AM, et al. Development of human mast cells in vitro. Proc Natl Acad Sci USA 1989; 86:10039-10043.
3. TC types of human mast cells by immunohistochemistry using new monoclonal antitryptase and anti-chymase antibodies. J Histochem Cytochem 1989;37: 1509-1515.
4. Irani AA, Schechter NM, Craig SS, et al. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986; 83:4464-4468.
5. Irani AA, Buckley R, Haynes B, et al. Selective depletion of T mast cells in intestinal mucosa of patients with defective lymphocyte function [Abstract]. J Allergy Clin Immunol 1987; 79:178.
6. Irani AA, Craig SS, DeBlois G, et al. Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. J Immunol 1987;138:4381-4386.
7. Cowen T, Trigg P, Eady RAJ. Distribution of mast cells in human dermis: development of a mapping technique. Br J Dermatol 1979;100:635-640.
8. Eady RAJ, Cowen T, Marshall TF, et al. Mast cell population density, blood vessel density and histamine content of normal human skin. Br J Dermatol 1979;100:623-633.
9. Mikhail GR, Miller-Milinska A. Mast cell population in human skin. J Invest Dermatol 1964;43:249-254.
10. Hellmstrom B, Holmgren H. Numerical distribution of mast cells in human skin and heart. Acta Anat (Basel) 1950;10:81-107.
11. Binazzi M, Rampichini L. Investigations on the regional distribution of mast cells in human skin. Ital Gen Rev Dermatol 1959;1:17-21.
12. Benyon RC, Lowman MA, Church MK. Human skin mast cells: their dispersion, purification and secretory characteristics. J Immunol 1987;138: 861-867.
13. Irani AA, Garriga MM, Metcalfe DD, Schwartz LB. Mast cells in cutaneous mastocytosis: accumulation of the MCTC type. Clin Exp Allergy 1990; 20:53-58.
14. Schwartz LB, Irani AA, Roller K, et al. Quantitation of histamine, tryptase and chymase in dispersed human t and tc mast cells. J Immunol 1987;138: 2611-2615.
15. TC type of human mast cell. J Immunol 1990;145: 2652-2661.
16. TC cells. J Immunol 1991;147: 247-253.
17. Goldstein SM, Kaempfer CE, Proud D, et al. Detection and partial characterization of a human mast cell carboxypeptidase. J Immunol 1987;139: 2724-2729.
18. Robinson C, Benyon RC, Holgate ST, Church MK. The IgE- and calcium-dependent release of eicosanoids and histamine from human cutaneous mast cells. J Invest Dermatol 1989;93: 397-404.
19. Taylor GW, Taylor I, Black P, et al. Urinary leukotriene E4 after antigen challenge in acute asthma and allergic rhinitis. Lancet 1989;i:584-588.
20. Baghestanian M, Bankl Hc, Sillaber C, et al. A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone. Leukemia 1996;10:159-166.
21. Lowman MA, Benyon RC, Church MK. Characterization of neuropeptide-induced histamine released from human dispersed skin mast cells. Br J Pharmacol 1988;95:121-130.
22. Caulfield JP, El Lati SG, Thomas G, Church MK. Dissociated human foreskin mast cells degranulate in response to anti-IgE and substance P. Lab Invest 1990;63:502-510.
23. Church MK, El Lati SG, Okayama Y. Biological properties of human skin mast cells. Clin Exp Allergy 1991; 21(Suppl 3):1-9.
24. Okayama Y, Benyon RC, Rees PH, et al. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. Clin Exp Allergy 1992;22: 401-409.
25. Irani AA, Schwartz LB, Schwanz LB, eds. Neutral proteases of mast cells. Basel: Karger, Neutral proteases as indicators of human mast cell heterogeneity. 1990:146-62.
26. 1-antihistamines on histamine and PGD(2) release from mast cells of human lung, tonsil, and skin. Allergy 1994;49:246-253.
27. Bito L, Dawson H, Levin E, et al. The concentrations of free amino acids and other electrolytes in cerebral spinal fluid, in vivo dialysate of brain, and in blood plasma in the dog. J Neurochem 1966;13:1057-1067.
28. Petersen LJ, Skov PS, Bindslev-Jensen C, Søndergaard J. Histamine release in immediate-type hypersensitivity reactions in intact human skin measured by microdialysis. A preliminary study. Allergy 1992;47:635-637.
29. Petersen LJ, Poulsen LK, Søndergaard J, Skov PS. The use of cutaneous microdialysis to measure substance P-induced histamine release in intact human skin in vivo. J Allergy Clin Immunol 1994;94:773-783.
30. Raud J, Dahlen S-E, Smedegard G, Hedqvist P. An intravital microscopic model for mast cell-dependent inflammation in the hamster cheek pouch. Acta Physiol Scand 1988;135:95-105.
31. Torebjork HE, Hallin RG. Identification of afferent C units in intact human skin. Brain Res 1974;67:387-403.
32. Skov PS, Norn S, Weeke B. A new method for detecting histamine release. Agents Actions 1984;14: 414-416.
33. Petersen LJ, Church MK, Skov PS. Histamine is released in the weal but not the flare following challenge of human skin in vivo: A microdialysis study. Clin Exp Allergy 1997;27: 284-296.
34. Lawrence ID, Warner JA, Cohan VL, et al. Bradykinin analog induce histamine release from human skin mast cells. Adv Exp Med Biol 1989;247A: 225-229.
35. Cohan VL, MacGlashan DWJ, Warner JA, et al. Mechanisms of mediator release from human skin mast cells upon stimulation by the bradykinin analog, [DArg0-Hyp3-DPhe7]bradykinin. Biochem Pharmacol 1991;41: 293-300.
36. Wallengren J, Hakanson R. Effects of capsaicin, bradykinin and prostaglandin E2 in the human skin. Br J Dermatol 1992;126:111-117.
37. Li Kam Wa TC, Cooke ED, Turner P. Effects of selective histamine antagonists on skin responses to intradermal bradykinin in healthy volunteers. J Pharm Pharmacol 1992;44:869-872.
38. 2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin. Clin Exp Dermatol 1996;21:33-37.
39. Burrows LJ, Skinner SP, Bewley AP, et al. Cetirizine inhibits bradykinin-induced weal and flare in human skin in the absence of histamine release.